Reports Q1 revenue $190M, consensus $188.0M. Non-GAAP gross margin was 31% in the quarter compared to 32% in Q1 of FY23. “Revenue of $190 million in the first quarter of fiscal 2024, was at the mid-point of our guidance, however unfavorable mix in both the Medical and Industrial segments impacted profitability.” said Sunny Sanyal, CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VREX:
